Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients
Clinical trial NCT05447013 · UNKNOWN
Trial details
- NCT number
- NCT05447013
- Sponsor
- George Papanicolaou Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2022-12-31
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.